Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam

Gregory Krauss, A. Bergin, R. E. Kramer, Y. W. Cho, S. G. Reich

Research output: Contribution to journalArticle

Abstract

Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.

Original languageEnglish (US)
Pages (from-to)411-412
Number of pages2
JournalNeurology
Volume56
Issue number3
StatePublished - Feb 13 2001

Fingerprint

etiracetam
Myoclonus
Anticonvulsants
Brain Injuries

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Krauss, G., Bergin, A., Kramer, R. E., Cho, Y. W., & Reich, S. G. (2001). Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam. Neurology, 56(3), 411-412.

Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam. / Krauss, Gregory; Bergin, A.; Kramer, R. E.; Cho, Y. W.; Reich, S. G.

In: Neurology, Vol. 56, No. 3, 13.02.2001, p. 411-412.

Research output: Contribution to journalArticle

Krauss, G, Bergin, A, Kramer, RE, Cho, YW & Reich, SG 2001, 'Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam', Neurology, vol. 56, no. 3, pp. 411-412.
Krauss G, Bergin A, Kramer RE, Cho YW, Reich SG. Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam. Neurology. 2001 Feb 13;56(3):411-412.
Krauss, Gregory ; Bergin, A. ; Kramer, R. E. ; Cho, Y. W. ; Reich, S. G. / Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam. In: Neurology. 2001 ; Vol. 56, No. 3. pp. 411-412.
@article{3504dee58188413384e3f15ceb698c55,
title = "Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam",
abstract = "Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.",
author = "Gregory Krauss and A. Bergin and Kramer, {R. E.} and Cho, {Y. W.} and Reich, {S. G.}",
year = "2001",
month = "2",
day = "13",
language = "English (US)",
volume = "56",
pages = "411--412",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam

AU - Krauss, Gregory

AU - Bergin, A.

AU - Kramer, R. E.

AU - Cho, Y. W.

AU - Reich, S. G.

PY - 2001/2/13

Y1 - 2001/2/13

N2 - Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.

AB - Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0035852626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035852626&partnerID=8YFLogxK

M3 - Article

C2 - 11171914

AN - SCOPUS:0035852626

VL - 56

SP - 411

EP - 412

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -